Biotech Stocks
Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T
Endpoints News
2h ago
Roughly a year after shedding half of its workforce, Arsenal Biosciences is trimming its headcount again by letting go of “the majority” of its staffers as a result of a pivot into in vivo CAR-T ...
Discussion
Sign in to join the discussion. Comments loading…